Vitamin D and the Indian Nutrimetabolic Phenotype: Insights from an Expert Panel Review
Journal of Diabetology · 18.11.2026
DOI: 10.4103/jod.jod_97_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetology, online erschienen am 18.11.2026. Verfasst von Sanjay Kalra und 12 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Vitamin D deficiency is highly prevalent in India despite abundant sunlight and may contribute to the broader Indian nutrimetabolic phenotype, characterized by central adiposity, insulin resistance, dyslipidemia, early β -cell dysfunction, and micronutrient insufficiencies. This expert review aimed to define the Indian nutrimetabolic phenotype, examine the contribution of vitamin D deficiency and related micronutrient factors, and provide practical guidance on screening, supplementation, and fortification strategies relevant to Indian clinical practice. A structured literature review was conducted using PubMed and Google Scholar, followed by a two-round Delphi process involving 14 endocrinologists. Evidence summaries and draft statements were rated anonymously, with consensus defined as ≥80% agreement; unresolved areas were refined during an in-person advisory board meeting. Consensus was reached on 22 expert insights organized under seven clinical questions and three thematic domains: phenotypic definition, prevention and risk management, and therapeutic supplementation principles. The panel concluded that the Indian nutrimetabolic phenotype is a modifiable construct shaped by diet, lifestyle, adiposity, metabolic risk, and micronutrient status and that vitamin D deficiency should be identified and corrected as part of comprehensive metabolic care, particularly in individuals with obesity, insulin resistance, type 2 diabetes mellitus/prediabetes, cardiovascular disease, and chronic kidney disease. Supplementation should be individualized according to baseline 25-hydroxyvitamin D levels, deficiency severity, body mass index, comorbidities, and safety considerations, with retesting after 8–12 weeks where appropriate. However, vitamin D should not be positioned as a standalone metabolic therapy or routine disease prevention strategy in vitamin D-sufficient individuals. Further studies in Indian populations are needed to validate population-specific thresholds, optimize dosing, and determine whether correction of deficiency improves clinically meaningful metabolic outcomes.
Zitieren
APA
Kalra, S., Kapoor, N., Bhattacharya, S., Lakhani, O. J., Selvan, C., Sharma, S., Nagendra, L., Bhavani, N., Dhingra, A., Das, S., Sharma, H., Kumar, A., & Kumar, K. V. S. H. (2026). Vitamin D and the Indian Nutrimetabolic Phenotype: Insights from an Expert Panel Review. Journal of Diabetology. https://doi.org/10.4103/jod.jod_97_26
Vancouver
Kalra S, Kapoor N, Bhattacharya S, Lakhani OJ, Selvan C, Sharma S, et al. Vitamin D and the Indian Nutrimetabolic Phenotype: Insights from an Expert Panel Review. Journal of Diabetology. 2026. doi:10.4103/jod.jod_97_26
BibTeX
@article{Kalra2026,
author = {Kalra, Sanjay and Kapoor, Nitin and Bhattacharya, Saptarshi and Lakhani, Om J. and Selvan, Chitra and Sharma, Sourabh and Nagendra, Lakshmi and Bhavani, Nisha and Dhingra, Atul and Das, Sambit and Sharma, Himanshu and Kumar, Ashok and Kumar, K. V. S. Hari},
title = {Vitamin D and the Indian Nutrimetabolic Phenotype: Insights from an Expert Panel Review},
journal = {Journal of Diabetology},
year = {2026},
doi = {10.4103/jod.jod_97_26}
}
EUVIMED